Default delay instalment payment until September 2020 is another factor .. there are only 310,000 application to further delay to December 2020 .. 97 % is approved by relevant banks ..
BEIJING, Sept 15 (AFP): A China-developed coronavirus vaccine could be ready for the public as early as November, a Chinese official has told state television, as the global race to clear the final round of trials heats up.
Chinese manufacturers have been bullish about development, with companies Sinovac Biotech and Sinopharm even putting their vaccine candidates on display at a trade fair in Beijing this month.
China's CNBG, Sinovac find more countries to test Covid-19 vaccines Roxanne Liu & Tony Munroe / Reuters
September 05, 2020 19:39 pm
BEIJING (Sept 5): China National Biotec Group (CNBG) and Sinovac Biotech Ltd said on Saturday four more countries have agreed to run late-stage clinical tests of their coronavirus vaccine candidates, as China steps up its efforts in the global race.
Serbia and Pakistan are among the new countries agreeing to Phase 3 trials, as the two companies seek more data overseas amid dwindling new cases in China.
Serbia will test two vaccines developed by CNBG's Wuhan and Beijing units, and Pakistan will test the Beijing unit's candidate, the company told Reuters. CNBG's Phase 3 trials are expected to involve 50,000 people in about 10 countries, said CNBG vice president Zhang Yuntao. Trials have already begun in United Arab Emirates, Bahrain, Peru, Morocco, Argentina and Jordan
Zhang said foreign countries have expressed interest in ordering a combined 500 million doses of its vaccines.
CNBG is expected to be able to produce 300 million doses of vaccine a year once it upgrades manufacturing techniques, and is working on a plan to raise its annual capacity to 1 billion doses, Zhang said.
Sinovac's vaccine candidate CoronaVac, being tested in Brazil and Indonesia, also obtained approvals from two other countries for Phase 3 trials, said Helen Yang, senior director of global strategy and business development at Sinovac.
The IBs are shorting the Topglove and Supermax to cover their massive losses from the "cheap" call warrants which they didn't foresee the price explosion. Nobody knew that Covid-19 is coming and its devastating effects on human lives hence came the staggering demand for gloves. Some IBs are seriously affected financially, you know who they are.
Now short selling is not allow so negative report on Top Glove hopefully to press down the price .
Demand of glove will be keep increasing with the coming of second wave...new glove player will face raw material shortage so choose wisely on the company you intend to invest. Personally I choose Carplus as it is going to double production with newly additional lines install and its partner Anseel Australia with well establised worldwide distribution networks
There seem to be so many call warrants for TG n Max from Sept to December..The total warrant value is also very huge should the IB compensates against the mother share..We know that glove demand is greater than ever with the ASP ever increasing n the profit margin is super huge as seen during the QR..There are also many sentiments especially on vaccine which has failed or postponed..This indicates that the Glove price is really low and should fly by right..Now just to enlighten, can someone confirm though it is purely based on facts, if the IB is gonna press the gloves mother share lower to offset the warrant price then this will go on till December though in between we would see the uptrend rebound otherwise is will be pressed lower before we see the uptrend next year once all the call warrant expires..Will this assumption be correct at least on paper..I see this as a risk though as for now till Nov we can still see that the demand isn't gonna slow any further but next year is abit too far to think for now..
We know that Careplus & second tier gloves are dependant on the Big 4 in someway..Will this be a stumbling block..TQ..
It is fortunate for us that short selling is not allow as imposed by Bursa Malaysia at this juncture otherwise the IB can easily press down the price by short selling the share with their huge reserved fund . Maybe the short selling factor is overlook by IB when issueing the call warrant as now facing huge losses when the call warrant approaching mature date..without the short selling activity it is not easy to press down the mother share price as you can seen in Top Globe with good earning report and share buyback . Of course they can issue report like Macquring IB downgrade Top Globe at RM 5 but the price just keep upping , majority of the investor will ignore the lousy report issued by this IB. How can you block the rising when smart money keep on flowing to the stock unless you short selling it during rising which is not allow presently?
@Tuapuikia, I am not that far from u in terms of lots, just that slightly lesser..Value wise I am not that far from u 2 despite after averaging..I am not sure how the IB's are going to pan out the game since the hot story on warrant is very disturbing n this can go till mid Dec..Now, let's see since QR for Carepls n Supermax is the last bait if u intend to make a move..Of course on paper, end 2020 or early 2021 we expect price to rocket for gloves but that's too far to forecast for now..Think wisely before making ur move..I believe it will go up but reaching RM 4 max maybe in short term hopefully by October if it could realise..
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Mikecyc
45,125 posts
Posted by Mikecyc > 2020-09-19 15:01 | Report Abuse
as they are just acting without post fact views to support ..